BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 683130)

  • 21. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methyl-CCNU inclinical cancer therapy.
    Wasserman TH; Slavik M; Carter SK
    Cancer Treat Rev; 1974 Dec; 1(4):251-69. PubMed ID: 4377543
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
    Moertel CG
    JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of methyl-C.C.N.U. and 5-fluorouracil in colorectal cancer.
    Barrett A; Gazet JC; Bradbeer JW; Peckham MJ
    Lancet; 1978 Jul; 2(8080):101-2. PubMed ID: 78265
    [No Abstract]   [Full Text] [Related]  

  • 29. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
    Fleischer I; Wainstein R; Jovtis S; Colombato LO
    Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
    Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
    Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
    [No Abstract]   [Full Text] [Related]  

  • 32. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
    Sordillo PP; Magill GB
    Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for known residual disease after resection of gastric and colorectal cancer.
    Giles GR; Lawton JO
    Recent Results Cancer Res; 1978; 68():212-6. PubMed ID: 752858
    [No Abstract]   [Full Text] [Related]  

  • 36. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A; Kolarić K
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract]   [Full Text] [Related]  

  • 37. Response of metastatic cloacogenic carcinoma to treatment with semustine.
    Zimm S; Wampler GL
    Cancer; 1981 Dec; 48(12):2575-6. PubMed ID: 7306917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II study of melphalan in colorectal carcinoma.
    DiBenedetto J; Moayeri H; Evans JT; Mittelman A
    Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.